IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma
Low-grade IDH-mutant gliomas: from standard post-surgical treatments to novel IDH inhibitors
Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas
Identification of intrinsic imaging subtypes using clustering analysis based on dynamic contrast-enhanced magnetic resonance imaging radiomics features for gliomas: preliminary associations with gene expression profiles
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma
The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density
Epidemiological analysis of adult-type diffuse lower-grade gliomas and incidence and prevalence estimates of diffuse IDH-mutant gliomas in France
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ